Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

It's never to late to learn valuable life lessons. These people are sharing their sudden realizations.

Rowan University biology professor Natasha Shylo is exploring left-right asymmetry development with a grant from the National Institutes of Health.

Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. If you aren’t ...

Dunkleosteus is often presented as one of the most formidable predators of the Devonian seas, yet much of its biology remains ...

Explore the implications of a $2 million detransitioner lawsuit win and its impact on gender surgery laws and medical ...

AGOURA HILLS, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

A surprisingly small detail in the skin may play an outsized role in how young skin looks and how well it repairs scars. Researchers say the clue is a microscopic structure found in humans, pigs, and ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

Tiny folds anchoring human skin, called 'rete ridges,' form soon after birth. They show an early-life window that could reshape aging.